Avicanna Closes $2.8 Million Oversubscribed Financing – Biotech CBD Pharmaceuticals

August 17, 2022 jeminicap 0 Comments

AVICANNA ANNOUNCES CLOSING OF STRATEGIC PRIVATE PLACEMENT Avicanna Inc. has closed a strategic non-brokered private placement offering of 7,949,433 units of the company at a price of 35 cents per unit for aggregate gross proceeds of approximately $2,782,000. Each Unit is comprised of one common share in the capital of the Company (each, a “Common […]

AVICANNA and EI Ventures Enters in Agreement to Develop and Commercialize Adaptogen Nutraceuticals

July 4, 2022 jeminicap 0 Comments

AVICANNA AND EI. VENTURES ENTER INTO AN AGREEMENT TO DEVELOP AND COMMERCIALIZE ADAPTOGEN NUTRACEUTICALS Avicanna Inc. has entered into an intellectual property licensing and royalty agreement (IPLRA) with Ei.Ventures Inc. to develop and commercialize functional fungi-based products. “Over the past six years our team established a scientific platform that has led to the commercialization of […]